|
| 盟科药业-U(688373)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2025-08-05 | 28325.03 | 43.23% | 64890.20 | 630.81 | 36045.17 | 55.01% | 首发原股东限售股份 | | 2024-08-05 | 520.00 | 0.79% | 36565.17 | 28955.84 | 34441.63 | 52.57% | 首发战略配售股份 | | 2024-07-15 | 1340.44 | 2.05% | 36045.17 | 29475.84 | 34441.63 | 52.57% | 首发原股东限售股份 | | 2024-04-23 | 263.10 | 0.40% | 34704.73 | 30816.28 | 34441.63 | 52.57% | 首发原股东限售股份 | | 2023-08-07 | 21961.63 | 33.52% | 34538.30 | 30982.71 | 12576.67 | 19.19% | 首发原股东限售股份 | | 2023-02-06 | 611.23 | 0.93% | 12576.67 | 52944.34 | 12576.67 | 19.19% | 首发机构配售股份 | | 2022-08-05 | 11868.77 | 18.11% | 11868.77 | 53652.24 | 11868.77 | 18.11% | 首发一般股份 |
|